Tyson LB - Search Results

1

Dose-ranging trial of zacopride: the emetic antiemetic?

Pisters KM, Kris MG, Tyson LB, Clark RA, Gralla RJ. Pisters KM, et al. Among authors: tyson lb. J Natl Cancer Inst. 1992 May 6;84(9):717-8. doi: 10.1093/jnci/84.9.717. J Natl Cancer Inst. 1992. PMID: 1569606 Clinical Trial. No abstract available.

2

Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase II study and a review of completed trials to manage delayed emesis.

Kris MG, Tyson LB, Clark RA, Gralla RJ. Kris MG, et al. Among authors: tyson lb. Cancer. 1992 Aug 15;70(4 Suppl):1012-6. Cancer. 1992. PMID: 1386282 Review.

3

Phase II trials of the serotonin antagonist GR38032F for the control of vomiting caused by cisplatin.

Kris MG, Gralla RJ, Clark RA, Tyson LB. Kris MG, et al. Among authors: tyson lb. J Natl Cancer Inst. 1989 Jan 4;81(1):42-6. doi: 10.1093/jnci/81.1.42. J Natl Cancer Inst. 1989. PMID: 2521184 Clinical Trial.

4

Dose-ranging antiemetic trial of high-dose oral metoclopramide.

Tyson LB, Gralla RJ, Kris MG, Young CW, Clark RA. Tyson LB, et al. Am J Clin Oncol. 1989 Jun;12(3):239-43. doi: 10.1097/00000421-198906000-00012. Am J Clin Oncol. 1989. PMID: 2658539 Clinical Trial.

5

Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapy.

Kris MG, Gralla RJ, Clark RA, Tyson LB. Kris MG, et al. Among authors: tyson lb. J Clin Oncol. 1988 Apr;6(4):659-62. doi: 10.1200/JCO.1988.6.4.659. J Clin Oncol. 1988. PMID: 2965755

6

Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial.

Kris MG, Gralla RJ, Clark RA, Tyson LB, Groshen S. Kris MG, et al. Among authors: tyson lb. Cancer. 1987 Dec 1;60(11):2816-22. doi: 10.1002/1097-0142(19871201)60:11<2816::aid-cncr2820601137>3.0.co;2-7. Cancer. 1987. PMID: 3315176 Clinical Trial.

7

Randomized phase II trial comparing two versus three doses of ondansetron when used in combination with dexamethasone in patients receiving cisplatin > or = 100 mg/m2.

Tyson LB, Kris MG, Baltzer L, Pisters KM, Rigas JR, Clark RA. Tyson LB, et al. Am J Clin Oncol. 1994 Jun;17(3):269-72. doi: 10.1097/00000421-199406000-00018. Am J Clin Oncol. 1994. PMID: 8192116 Clinical Trial.

8

Enhancing the effectiveness of the specific serotonin antagonists. Combination antiemetic therapy with dexamethasone.

Kris MG, Baltzer L, Pisters KM, Tyson LB. Kris MG, et al. Among authors: tyson lb. Cancer. 1993 Dec 1;72(11 Suppl):3436-42. doi: 10.1002/1097-0142(19931201)72:11+<3436::aid-cncr2820721610>3.0.co;2-z. Cancer. 1993. PMID: 8242576 Review.

9

The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin.

Baltzer L, Kris MG, Tyson LB, Rigas JR, Pisters KM. Baltzer L, et al. Among authors: tyson lb. Cancer. 1994 Feb 1;73(3):720-3. doi: 10.1002/1097-0142(19940201)73:3<720::aid-cncr2820730336>3.0.co;2-3. Cancer. 1994. PMID: 8299095 Clinical Trial.

10

Dose-ranging antiemetic evaluation of the serotonin antagonist RG 12915 in patients receiving anticancer chemotherapy.

Baltzer L, Kris MG, Tyson LB, Rigas JR, Vreeland F, Pisters KM. Baltzer L, et al. Among authors: tyson lb. Cancer. 1993 Nov 1;72(9):2695-9. doi: 10.1002/1097-0142(19931101)72:9<2695::aid-cncr2820720928>3.0.co;2-s. Cancer. 1993. PMID: 8402492 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters